MediPharm Labs Corp (LABS.TO)
0.09
0.00 (0.00%)
CAD |
TSX |
May 06, 16:00
MediPharm Labs Debt to Equity Ratio: 0.0397 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
December 31, 2023 | 0.0397 |
September 30, 2023 | 0.0446 |
June 30, 2023 | 0.0461 |
March 31, 2023 | 0.0024 |
December 31, 2022 | 0.0093 |
September 30, 2022 | 0.0172 |
June 30, 2022 | 0.0188 |
March 31, 2022 | 0.00 |
December 31, 2021 | 0.00 |
September 30, 2021 | 0.0192 |
Date | Value |
---|---|
June 30, 2021 | 0.0158 |
March 31, 2021 | 0.0261 |
December 31, 2020 | 0.2285 |
September 30, 2020 | 0.2908 |
June 30, 2020 | 0.131 |
March 31, 2020 | 0.0788 |
December 31, 2019 | 0.0728 |
September 30, 2019 | 0.0465 |
June 30, 2019 | 0.0496 |
March 31, 2019 | 0.1751 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2021
0.2908
Maximum
Sep 2020
0.0599
Average
0.0397
Median
Dec 2023
Debt to Equity Ratio Benchmarks
Biocure Technology Inc | -- |
Core One Labs Inc | 0.0443 |
Nova Mentis Life Science Corp | 0.00 |
Nanosphere Health Sciences Inc | -- |
Lobe Sciences Ltd | -0.5227 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 63.94M |
Total Liabilities (Quarterly) | 10.93M |
Shareholders Equity (Quarterly) | 53.00M |
Current Ratio | 3.372 |
Net Debt Paydown Yield | -0.82% |